InMode (INMD) Non-Current Deferred Tax Liability (2018 - 2019)
InMode (INMD) posted Non-Current Deferred Tax Liability of $37000.0 for Q4 2019, up 236.36% sequentially from $11000.0 in Q4 2018, and up 236.36% YoY from $11000.0 in Q4 2018.
InMode (INMD) Non-Current Deferred Tax Liability (2018 - 2019) Analysis & Trends
InMode has reported Non-Current Deferred Tax Liability for 2 years, with the latest figure at $37000.0 in Q4 2019.
- Quarterly Non-Current Deferred Tax Liability rose 236.36% year-over-year to $37000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $37000.0 (up 236.36% YoY) and the FY2019 annual result came in at $37000.0, up 236.36% from the prior year.
- Non-Current Deferred Tax Liability improved to $37000.0 in Q4 2019 per INMD's latest filing, from $11000.0 in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $37000.0 in Q4 2019 and troughed at $11000.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | InMode | 912.51 Mn | 497.35 Mn | 71.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 37,000.00 |
| Dec 31, 2019 | 37,000.00 |
| Dec 31, 2018 | 11,000.00 |
| Dec 31, 2018 | 11,000.00 |